GTBIF

Green thumb industries inc

0.00 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Green thumb industries inc stock is down -100% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.15% of the previous 12 February’s closed higher than January.

About Green thumb industries inc

Green Thumb Industries Inc. manufactures, distributes, and sells various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including concentrates, edibles, and topical and other cannabis products under the Rythm, Dogwalkers, The Feel Collection, incredibles, Dr. Solomon's, Beboe, and other brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of March 25, 2021, it owned and operated 55 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.

  • Jelena Martinovic
    Colorado lawmakers have introduced a bipartisan bill that aims to remove a rule requiring cannabis products to be tested for a fungus called Aspergillus. The rule, which was implemented by the Colorado Marijuana Enforcement Division, resulted in 17 product recalls in 2023, the most in the last seven years. The bill, Senate Bill 24-076, also seeks to make other changes to cannabis business regulations in the state. It would address the issue of labelling mandates for THC-infused products made from remediated marijuana, allow dispensaries to sell consumable goods that don't contain THC or CBD, and extend cannabis licensure from one to two years without any changes in fees. The bill has been brought by the Marijuana Industry Group, which says it is time for Colorado to streamline its regulations, following the lead of states including Nevada, California, Oregon and Maryland.
  • Benzinga Insights
  • Maureen Meehan
    The DOJ's emphasis on the ongoing DEA rescheduling process suggests a potential willingness to reconsider cannabis's classification.
  • Nicolás Jose Rodriguez
    In his latest cannabis sector equity report, senior analyst Pablo Zuanic of Zuanic & Associates offers a detailed examination of the cannabis sector's landscape in the fourth quarter of 2023.
  • Nina Zdinjak
  • Benzinga Insights
  • Benzinga Insights
  • Jelena Martinovic
    Maryland residents spent a record $96.5m on cannabis products in December, according to data from the Maryland Cannabis Administration (MCA). Of that total, $61.5m came from recreational cannabis sales, while medical sales totaled around $35m for the month. Maryland has seen booming sales since the launch of the recreational market last summer. At the time, existing cannabis companies in the state switched to adult-use shops by paying an 8% one-time fee of their 2022 dispensary revenue not exceeding $2m. Licensed stores took in $20.9m in the first week of legal sales. In total, Maryland recorded $787.5m in sales of legal marijuana products in 2023. Over the same period, Rhode Islanders spent more than $107.8m on combined cannabis sales.
  • Jelena Martinovic
    On Friday, a New York regulator green-lighted two more marijuana multistate operators to transition to the recreational market from the medical. Fiorello Pharmaceuticals Inc. - owned by Green Thumb Industries Inc and running dispensaries in Manhattan, Long Beach, Rochester and Half Moon - and Citiva Medical LLC - owned by iAnthus Capital Holdings Inc. and operating medical dispensaries doing business as "Be" in Brooklyn, Wappingers Falls, Staten Island and Ithaca– were approved by the members of New York Cannabis Control Board (CCB) in the anonymous vote. In the meantime, on Jan. 12, Arkansans for Patient Access, a ballot committee, submitted a proposed ballot initiative to Arkansas Attorney General Tim Griffin to amend Amendment 98, the state's medical marijuana amendment. In Maine, a new push seeks to decriminalize the possession of small quantities of illegal drugs and allocate resources towards treating substance use disorder instead of enforcing punitive measures. More Floridians are opting to register as medical marijuana patients, at least according to the 2024 Physician Certification Pattern Review annual report that highlighted figures from fiscal year 2023.
  • Benzinga Insights